Dr. Sameh M. Abdelaal, MD

Dr. Abdelaal practices at Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center.

Dr. Abdelaal's NPI, 1770855652, was assigned on February 7, 2012. Dr. Abdelaal holds New Jersey license 25MA09344300.

Dr. Abdelaal's primary practice is Deborah Heart and Lung Center, at 200 Trenton Road, Browns Mills, NJ 08015 in Burlington County. The practice phone is (609) 893-6611.

Dr. Abdelaal's primary practice is Deborah Heart and Lung Center in Browns Mills, New Jersey, part of Deborah Heart and Lung Center. Dr. Abdelaal is also affiliated with Capital Health Medical Center - Hopewell. The medical group on file is Deborah Heart and Lung Center. Dmand AI also links Dr. Abdelaal to 3 more medical groups, 2 group practices and clinics and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdelaal practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Abdelaal's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Abdelaal is licensed in New Jersey.

CMS data shows 108 Medicare services from Dr. Abdelaal across 2 procedure codes in 2024, for 39 Medicare patients. Medicare paid $8,116 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Dr. Abdelaal in 2024. The largest group is 75 to 84, with 14 patients. 75% of them have atrial fibrillation, and 75% have high blood pressure. Their average risk score is 3.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdelaal's median patient age at 74, with 33% women.

In 2024, Dr. Abdelaal wrote 22 Medicare Part D claims. 95% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $1,572 in total drug cost. In 2018, CMS named 96 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Abdelaal for performance year 2024, reported as part of a group. Dr. Abdelaal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Abdelaal from 3 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $20.